Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression
Public ClinicalTrials.gov record NCT05554471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Prospective, Randomized, Controlled, Open Label Trial to Evaluate the Safety and Efficacy of Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression in Patients Who Have Undergone Endovascular Procedures Utilizing up to 12F Procedural Sheaths
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ReliaSeal is a clinical trial designed to evaluate safety and efficacy of use of MYNX CONTROL™ Venous Vascular Closure Device 6F-12F vs. manual compression to seal femoral access sites in patients who have undergone endovascular procedures utilizing up to 12F procedural sheaths in one or both limbs.
Study identification
- NCT ID
- NCT05554471
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 352 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2022
- Primary completion
- Jul 10, 2023
- Completion
- Jul 10, 2023
- Last update posted
- Apr 23, 2025
2022 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cardiovascular Research Center | Phoenix | Arizona | 85016 | — |
| Colorado Heart and Vascular PC | Lakewood | Colorado | 80228 | — |
| Baptist Health Miami Cardiac and Vascular Institute | Miami | Florida | 33176 | — |
| Palm Vascular Centers | Miami Beach | Florida | 33312 | — |
| Tampa Cardiovascular Interventions and Research | Tampa | Florida | 33614 | — |
| Saint Luke's Hospital of Kansas City | Kansas City | Missouri | 64111 | — |
| NC Heart and Vascular Research | Raleigh | North Carolina | 27607 | — |
| Hightower Clinical | Oklahoma City | Oklahoma | 73134 | — |
| South Oklahoma Heart Research | Oklahoma City | Oklahoma | 73135 | — |
| OnSite Clinical Solutions | Rock Hill | South Carolina | 28277 | — |
| Erlanger Health System | Chattanooga | Tennessee | 37403 | — |
| Medical City Dallas Hospital | Dallas | Texas | 75230 | — |
| Rio Grande Regional Hospital | McAllen | Texas | 78503 | — |
| North Dallas Research Associates | McKinney | Texas | 75069 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05554471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05554471 live on ClinicalTrials.gov.